Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
Open Access
- 11 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 13 (4), e13390
- https://doi.org/10.15252/emmm.202013390
Abstract
Immunogenicity is considered one important criterion for progression of candidate vaccines to further clinical evaluation. We tested this assumption in an infection and vaccination model for malaria pre‐erythrocytic stages. We engineered Plasmodium berghei parasites that harbour a well‐characterised epitope for stimulation of CD8+ T cells, either as an antigen in the sporozoite surface‐expressed circumsporozoite protein or the parasitophorous vacuole membrane associated protein upregulated in sporozoites 4 (UIS4) expressed in exo‐erythrocytic forms (EEFs). We show that the antigen origin results in profound differences in immunogenicity with a sporozoite antigen eliciting robust, superior antigen‐specific CD8+ T‐cell responses, whilst an EEF antigen evokes poor responses. Despite their contrasting immunogenic properties, both sporozoite and EEF antigens gain access to antigen presentation pathways in hepatocytes, as recognition and targeting by vaccine‐induced effector CD8+ T cells results in high levels of protection when targeting either antigen. Our study is the first demonstration that poorly immunogenic EEF antigens do not preclude their susceptibility to antigen‐specific CD8+ T‐cell killing, which has wide‐ranging implications on antigen prioritisation for next‐generation pre‐erythrocytic malaria vaccines.Funding Information
- Lister Institute of Preventive Medicine
- Wellcome Trust (106917/Z/15/Z)
- European Commission
- Chica and Heinz Schaller Foundation
- Agence Nationale de la Recherche (ANR‐11‐LABX‐0024)
- Royal Society (UF0762736, UF120026, RG130034)
- National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/L000601/1)
This publication has 54 references indexed in Scilit:
- Location of the CD8 T Cell Epitope within the Antigenic Precursor Determines Immunogenicity and Protection against the Toxoplasma gondii ParasitePLoS Pathogens, 2013
- CSP—A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by HepatocytesPLOS ONE, 2012
- Identification of an AP2-family Protein That Is Critical for Malaria Liver Stage DevelopmentPLOS ONE, 2012
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibodyNature Communications, 2011
- The Puf-Family RNA-Binding Protein Puf2 Controls Sporozoite Conversion to Liver Stages in the Malaria ParasitePLOS ONE, 2011
- Dendritic Cells and Hepatocytes Use Distinct Pathways to Process Protective Antigen from Plasmodium in vivoPLoS Pathogens, 2011
- The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian hostThe Journal of Experimental Medicine, 2011
- Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated SporozoitesPLoS Pathogens, 2010
- Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8 + T-Cell ResponsesInfection and Immunity, 2010
- A combined transcriptome and proteome survey of malaria parasite liver stagesProceedings of the National Academy of Sciences of the United States of America, 2008